This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Celldex Therapeutics Inc (CLDX)

NASDAQ: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash and Equivalents 28.02M 169.40M 24.90M 11.90M
Receivables 427.00K 489.00K 44.00K 170.00K
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 204.98M 305.19M 85.11M 54.68M
Property, Plant & Equipment, Gross 24.76M 21.96M 19.53M 19.46M
Accumulated Depreciation & Depletion 14.22M 11.99M 12.32M 10.37M
Property, Plant & Equipment, Net 10.54M 9.97M 7.20M 9.09M
Intangibles 21.81M 22.82M 23.83M 24.92M
Other Non-Current Assets 1.72M 148.00K 424.00K 329.00K
Total Non-Current Assets 43.03M 41.91M 40.43M 43.31M
Liabilities & Shareholder Equity
Total Assets 248.01M 347.10M 125.54M 97.99M
Accounts Payable 2.60M 2.24M 745.00K 935.00K
Short Term Debt 2.59M 0.00 5.59M 6.14M
Other Current Liabilities 0.00 928.00K 388.00K 219.00K
Total Current Liabilities 24.49M 20.35M 17.68M 14.30M
Long Term Debt 0.00 0.00 5.75M 9.01M
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 11.86M 6.95M 6.34M 5.97M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 11.86M 6.95M 12.08M 14.97M
Total Liabilities 36.35M 27.30M 29.77M 29.27M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 211.66M 319.80M 95.77M 68.72M
Common Par 90.00K 89.00K 64.00K 44.00K
Additional Paid In Capital 672.74M 662.72M 357.09M 271.03M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -463.76M -345.68M -264.13M -205.01M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 2.59M 2.67M 2.74M 2.65M
Total Capitalization 211.66M 319.80M 101.52M 77.73M
Total Equity 211.66M 319.80M 95.77M 68.72M
Total Liabilities & Stock Equity 248.01M 347.10M 125.54M 97.99M
Total Common Shares Outstanding 89.59M 89.25M 64.36M 44.21M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 89.40M 79.78M 57.71M 39.50M
Diluted Weighted Shares Outstanding 89.40M 79.78M 57.71M 39.50M
Number of Employees 159 120 106 103
Number of Part-Time Employees 2 9 6 0

CLDX Celldex Therapeutics Inc

Chart of CLDX

Analysts Ratings for CLDX

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 8 8 8 8
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

Brokerage Partners

CLDX Chatter

Select the service that is right for you!

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs